| 摘要 |
The present invention relates to novel, improved methods for regulating in a mammal at least one of body weight, body fat, food consumption, lipid metabolism and glucose metabolism. Administration of a D1 or D2 agonist or both in the morning, combined with administration of a 5HT1B receptor subtype agonist at night results in reduction in food consumption, body weight, serum glucose levels and total body fat. |
